opipramol has been researched along with Motor Neuron Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barcikowska, M; Blair, IP; Brooks, WS; Coupland, KG; Dobson-Stone, C; Halliday, GM; Karlström, H; Kwok, JB; Loy, CT; Luty, AA; Maruszak, A; Mather, KA; Panegyres, PK; Sachdev, PS; Schofield, PR; Sobow, T; Tchorzewska, J; Williams, KL; Zekanowski, C | 1 |
1 other study(ies) available for opipramol and Motor Neuron Disease
Article | Year |
---|---|
Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.
Topics: Aged; Aged, 80 and over; Brain; Cell Line, Transformed; DNA-Binding Proteins; Female; Frontotemporal Lobar Degeneration; Haloperidol; Humans; Lymphocytes; Male; Middle Aged; Motor Neuron Disease; Mutation; Opipramol; Pedigree; Phenylacetates; Pyrrolidines; Receptors, sigma; RNA-Binding Protein FUS; Sigma-1 Receptor | 2010 |